Wenzhou Gestational Diabetes Cohort

Study acronym: WGDC
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Primary completion date changed from estimate of Mar 21, 2026 to Nov 1, 2025
    • Study completion pushed from Mar 21, 2033 to Mar 21, 2035
    • Site details revised
    • Collaborators: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
  2. Primary completion date: Mar 21, 2024 to Mar 21, 2026v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Westlake University
13 trials monitored
See 2 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
The Wenzhou Gestational Diabetes Cohort (WGDC) is a prospective cohort study among women with gestational diabetes mellitus (GDM) during pregnancy and their offspring living in Wenzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with GDM over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of the WGDC is to investigate the association of dietary and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the patients with long-term metabolic health of the women and their offspring.
Trial Details
NCT Number NCT05794152
Lead Sponsor Westlake University
Collaborators: Wenzhou People's Hospital
Conditions
(from sponsor)		 Gestational Diabetes Mellitus, Intrauterine Hyperglycemia, Birth Outcome, Adverse, Nutrition, Healthy
Related terms Diabetes, Gestational, Pregnancy Complications
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov